GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Alibaba Health Information Technology Ltd (HKSE:00241) » Definitions » Piotroski F-Score

Alibaba Health Information Technology (HKSE:00241) Piotroski F-Score : 6 (As of May. 02, 2024)


View and export this data going back to 1972. Start your Free Trial

What is Alibaba Health Information Technology Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Alibaba Health Information Technology has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Alibaba Health Information Technology's Piotroski F-Score or its related term are showing as below:

HKSE:00241' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 5   Max: 8
Current: 6

During the past 13 years, the highest Piotroski F-Score of Alibaba Health Information Technology was 8. The lowest was 1. And the median was 5.


Alibaba Health Information Technology Piotroski F-Score Historical Data

The historical data trend for Alibaba Health Information Technology's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alibaba Health Information Technology Piotroski F-Score Chart

Alibaba Health Information Technology Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 4.00 8.00 2.00 6.00

Alibaba Health Information Technology Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.00 - 6.00 -

Competitive Comparison of Alibaba Health Information Technology's Piotroski F-Score

For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alibaba Health Information Technology's Piotroski F-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Alibaba Health Information Technology's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar23) TTM:Last Year (Mar22) TTM:
Net Income was HK$608 Mil.
Cash Flow from Operations was HK$291 Mil.
Revenue was HK$30,483 Mil.
Gross Profit was HK$6,494 Mil.
Average Total Assets from the begining of this year (Mar22)
to the end of this year (Mar23) was (23675.75 + 23631.661) / 2 = HK$23653.7055 Mil.
Total Assets at the begining of this year (Mar22) was HK$23,676 Mil.
Long-Term Debt & Capital Lease Obligation was HK$46 Mil.
Total Current Assets was HK$16,987 Mil.
Total Current Liabilities was HK$6,193 Mil.
Net Income was HK$-327 Mil.

Revenue was HK$25,372 Mil.
Gross Profit was HK$5,065 Mil.
Average Total Assets from the begining of last year (Mar21)
to the end of last year (Mar22) was (21156.321 + 23675.75) / 2 = HK$22416.0355 Mil.
Total Assets at the begining of last year (Mar21) was HK$21,156 Mil.
Long-Term Debt & Capital Lease Obligation was HK$105 Mil.
Total Current Assets was HK$16,726 Mil.
Total Current Liabilities was HK$5,946 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Alibaba Health Information Technology's current Net Income (TTM) was 608. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Alibaba Health Information Technology's current Cash Flow from Operations (TTM) was 291. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar22)
=607.548/23675.75
=0.02566119

ROA (Last Year)=Net Income/Total Assets (Mar21)
=-327.425/21156.321
=-0.01547646

Alibaba Health Information Technology's return on assets of this year was 0.02566119. Alibaba Health Information Technology's return on assets of last year was -0.01547646. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Alibaba Health Information Technology's current Net Income (TTM) was 608. Alibaba Health Information Technology's current Cash Flow from Operations (TTM) was 291. ==> 291 <= 608 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=45.971/23653.7055
=0.0019435

Gearing (Last Year: Mar22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar21 to Mar22
=104.505/22416.0355
=0.00466206

Alibaba Health Information Technology's gearing of this year was 0.0019435. Alibaba Health Information Technology's gearing of last year was 0.00466206. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar23)=Total Current Assets/Total Current Liabilities
=16986.731/6193.221
=2.74279426

Current Ratio (Last Year: Mar22)=Total Current Assets/Total Current Liabilities
=16726.079/5945.62
=2.81317659

Alibaba Health Information Technology's current ratio of this year was 2.74279426. Alibaba Health Information Technology's current ratio of last year was 2.81317659. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Alibaba Health Information Technology's number of shares in issue this year was 13541.58. Alibaba Health Information Technology's number of shares in issue last year was 13482.634. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=6493.79/30482.939
=0.21303031

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=5065.096/25371.903
=0.19963406

Alibaba Health Information Technology's gross margin of this year was 0.21303031. Alibaba Health Information Technology's gross margin of last year was 0.19963406. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar22)
=30482.939/23675.75
=1.28751735

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar21)
=25371.903/21156.321
=1.19925875

Alibaba Health Information Technology's asset turnover of this year was 1.28751735. Alibaba Health Information Technology's asset turnover of last year was 1.19925875. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+0+1+0+0+1+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Alibaba Health Information Technology has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Alibaba Health Information Technology  (HKSE:00241) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Alibaba Health Information Technology Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Alibaba Health Information Technology's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Alibaba Health Information Technology (HKSE:00241) Business Description

Traded in Other Exchanges
Address
Guanghua Road, 65/F, CITIC Tower, Building 1, No.10, Jianwai Subdistrict, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app called Yilu or "Dr. Deer", although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 97% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.

Alibaba Health Information Technology (HKSE:00241) Headlines

No Headlines